Trial Profile
An Open-Label, Randomised, Multi-Centre, Phase IIIb, Parallel Group Study to Compare the Efficacy and Safety of Rosuvastatin and Atorvastatin in Subjects With Type IIa and IIb Hypercholesterolaemia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Jun 2013
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Rosuvastatin (Primary)
- Indications Cardiovascular disorders; Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms DISCOVERY
- Sponsors AstraZeneca
- 01 Apr 2009 Actual end date (Feb 2005) added as reported by ClinicalTrials.gov.
- 10 Sep 2008 New trial record.